Pharmacare Premium

Pharmacare Premium is a Malta-based pharmaceutical company specializing in the development and manufacturing of high-potency generic drugs, with a primary focus on oncology. The company operates a state-of-the-art EU-GMP certified facility specifically designed to handle highly potent active pharmaceutical ingredients (HAPIs) in oral solid dosage forms. Pharmacare Premium provides a range of services including contract development and manufacturing (CDMO), as well as its own portfolio of generic products. Its strategic location in Malta allows for early market entry into the EU and other international markets through the Bolar provision. The company is a joint venture between Palestinian and Maltese investors, aiming to provide high-quality, affordable cancer treatments globally.